Exagen Market Cap

Exagen has a market cap or net worth of $152.81 million as of June 26, 2025. Its market cap has increased by 335.41% in one year.

Market Cap

152.81M

Enterprise Value

165.17M

1-Year Change

335.41%

Ranking

#3882

Market Cap Chart

Since September 19, 2019, Exagen's market cap has increased from $63.11M to $152.81M, an increase of 142.14%. That is a compound annual growth rate of 16.56%.

Market Cap History

Date	Market Cap	% Change
Jun 25, 2025	148.00M	104.66%
Dec 31, 2024	72.31M	113.18%
Dec 29, 2023	33.92M	-13.39%
Dec 30, 2022	39.17M	-79.17%
Dec 31, 2021	187.99M	12.56%
Dec 31, 2020	167.01M	-47.65%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	691.83B
Johnson & Johnson	364.09B
AbbVie	324.59B
Novo Nordisk	309.67B
UnitedHealth Group	272.76B
Abbott Laboratories	231.85B
Novartis AG	229.25B
AstraZeneca	218.15B

Market Cap Rankings